Angpt2-binding and Tie2-activating antibody (ABTAA), which induces oligomerisation of Angpt2 and subsequently activates Tie2, was used as intervention treatment in sepsis-associated microvascular dysfunction (171). The gene discussed is ANGPT2; the disease is Sepsis.